The spectrum of manifestations in desmoplakin gene (DSP) spectrin repeat 6 domain mutations: Immunophenotyping and response to ustekinumab
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 78 (3) , 498-505.e2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implicationsJournal of Allergy and Clinical Immunology, 2015
- Loss of desmoglein 1 associated with palmoplantar keratoderma, dermatitis and multiple allergiesBritish Journal of Dermatology, 2014
- Desmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wastingNature Genetics, 2013
- Involvement of IL-9 in Th17-Associated Inflammation and Angiogenesis of PsoriasisPLOS ONE, 2013
- Expanding the phenotype associated with a desmoplakin dominant mutation: Carvajal/Naxos syndrome associated with leukonychia and oligodontiaInternational Journal of Cardiology, 2012
- Assessment of Pruritus Intensity: Prospective Study on Validity and Reliability of the Visual Analogue Scale, Numerical Rating Scale and Verbal Rating Scale in 471 Patients with Chronic PruritusActa Dermato-Venereologica, 2012
- Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalitiesJournal of Allergy and Clinical Immunology, 2011
- Effective Narrow-Band UVB Radiation Therapy Suppresses the IL-23/IL-17 Axis in Normalized Psoriasis PlaquesJournal of Investigative Dermatology, 2010
- A New Hypo/Oligodontia SyndromeJournal of Dental Research, 2010
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)The Lancet, 2008